Frequency News and Research

RSS

Excreted antibiotics become potential sources of antibiotic resistant genes

When an antibiotic is consumed, researchers have learned that up to 90 percent passes through a body without metabolizing. This means the drugs can leave the body almost intact through normal bodily functions.

9 Dec 2010

New software predicts key information about nasal insulin treatment regimens in type 1 diabetes

A La Jolla Institute team, led by leading type 1 diabetes researcher Matthias von Herrath, M.D., has demonstrated the effectiveness of a recently developed computer model in predicting key information about nasal insulin treatment regimens in type 1 (juvenile) diabetes. Development of the software, the Type 1 Diabetes PhysioLab- Platform, was funded through the peer-reviewed grant program of the American Diabetes Association.

9 Dec 2010

Urgent reform of Medicaid-financed community care for ADHD children needed

The enactment of the Patient Protection and Affordable Care Act of 2010 expands Medicare benefits to scores of previously uninsured individuals including many of our nation's children. While access to treatment is laudable, the quality of such treatment is the subject of an article in the December issue of the Journal of the American Academy of Child and Adolescent Psychiatry.

9 Dec 2010

L. reuteri Protectis reduces frequency of regurgitation by 80% in infants

The study showed that infants supplemented with L. reuteri Protectis reduced the frequency of regurgitation by 80 %. Gastric emptying was significantly accelerated compared to placebo.

8 Dec 2010

Frequent sexual intercourse improves marital satisfaction for neurotic newlyweds

People who are neurotic often have more difficulty with relationships and marriage. But if neurotic newlyweds have frequent sexual relations, their marital satisfaction is every bit as high as their less neurotic counterparts, according to a study in the current Social Psychological and Personality Science (published by SAGE).

8 Dec 2010

Three abstracts on Defibrotide presented at ASH Annual Meeting

Gentium S.p.A. today announced that three abstracts on Defibrotide were presented at the 52nd Annual Meeting and Exposition of the American Society of Hematology held at the Orange County Convention Center in Orlando, Florida, December 4-7, 2010.

8 Dec 2010

Study examines impact of poor care coordination on quality, cost of care in America

Many Americans seek medical treatment from a variety of care providers and often must play the role of informing each doctor what the others are recommending or prescribing. This fragmented experience of poorly coordinated care is due in part to a lack of consistent systems and processes in place to coordinate care across providers and facilities.

8 Dec 2010

School-based ASMA program helps adolescents improve asthma management, quality of life

A school-based intervention program designed for adolescents with asthma significantly improves asthma management and quality of life for the students who participate, and reduces asthma morbidity, according to researchers in New York City, who studied the effect of the program aimed at urban youth and their medical providers.

8 Dec 2010

Positive data from Celator's CPX-351 Phase 2 study in newly-diagnosed AML presented at 52nd ASH

Celator Pharmaceuticals today announced positive clinical data in elderly patients with newly-diagnosed acute myeloid leukemia (AML) treated with CPX-351 (Cytarabine:Daunorubicin) Liposome Injection. Data were presented from the podium at the 52nd American Society of Hematology (ASH) Annual Meeting in Orlando, Florida.

8 Dec 2010

Mobile phones use during pregnancy linked to behavioural problems in kids: Study

A new study finds that pregnant mums who regularly use mobile phones may be more likely to have children with behavioral problems, especially if these kids themselves start using mobile phones in their first seven years.

7 Dec 2010

Data analysis reveals significant risk factors for sudden unexpected death in epilepsy

Sudden unexpected death in epilepsy (SUDEP) is the most common condition-related cause of death in chronic epilepsy. Case-control studies using living people with epilepsy as controls have aimed at identifying factors that distinguish the epilepsy patient at risk of SUDEP, but there are disagreements between studies and a lack of precision in the risk estimates attributed, in part, to the small number of cases in each study.

7 Dec 2010

New analysis evaluates association between hemolysis, mortality in patients with PNH

Alexion Pharmaceuticals, Inc. today announced the presentation of an analysis from the National Data Registry in South Korea that evaluated the association between hemolysis and mortality in patients with paroxysmal nocturnal hemoglobinuria.

7 Dec 2010

Screening for CCDC40 gene mutations may help determine risk for congenital heart defects

A gene that can cause congenital heart defects has been identified by a team of scientists, including a group from Princeton University. The discovery could lead to new treatments for those affected by the conditions brought on by the birth defect.

7 Dec 2010

NovaBay Pharmaceuticals, Galderma expand their multi-year collaboration agreement

NovaBay Pharmaceuticals, Inc., a clinical stage biotechnology company developing first-in-class, anti-infective compounds for the treatment and prevention of antibiotic-resistant infections, and Galderma, a global leading pharmaceutical company dedicated exclusively to the field of dermatology, announce the expansion of their multi-year collaboration agreement. Based on positive data assessing the activity of NovaBay's Aganocide compounds against impetigo, Galderma has agreed to exercise its option for this indication.

6 Dec 2010

First patient dosed with rFVIIIFc in A-LONG trial

Biogen Idec and Swedish Orphan Biovitrum today announced that the first patient has been dosed with the companies' long-lasting recombinant Factor VIII Fc fusion protein (rFVIIIFc) in a global registrational clinical trial. The study, called A-LONG, is an open-label, multicenter, Phase 2/3 study designed to evaluate the safety, pharmacokinetics and efficacy of rFVIIIFc in previously-treated hemophilia A patients.

6 Dec 2010

Mothers exposure to farm animals and cats during pregnancy lowers risk of atopic dermatitis in children

Children whose mothers are exposed to farm animals and cats are better protected against atopic dermatitis and are less likely to develop this painful inflammation of the skin in their first two years of life. A group of researchers from the University of Zurich and other universities have published evidence supporting this theory in the Journal of Allergy & Clinical Immunology.

3 Dec 2010

Fourteen cases identified on E. coli infection related to raw milk consumption in Connecticut

Raw milk is consumed by an estimated 1-3 percent of the United States population. Raw milk and raw cheeses are responsible for almost 70 percent of reported dairy outbreaks. On July 16, 2008, the Connecticut Department of Public Health identified two unrelated children who had experienced hemolytic uremic syndrome after consuming raw milk from the same farm. The authors investigated the situation further and found more cases of people affected by raw milk from the same farm.

3 Dec 2010

Alcohol drinking pattern impacts coronary heart disease

A fascinating study published in the BMJ shows that although the French drink more than the Northern Irish each week, as they drink daily, rather than more on less occasions, the French suffered from considerably less coronary heart disease than the Northern Irish.

3 Dec 2010

One-third of LGBT youth attempt suicide

One-third of lesbian, gay, bisexual and transgender youth have attempted suicide in their lifetime -- a prevalence comparable to urban, minority youth -- but a majority do not experience mental illness, according to a report by researchers at the University of Illinois at Chicago.

2 Dec 2010

Oncolytics initiates enrollment in Phase II ovarian cancer study

Oncolytics Biotech Inc. announced today the start of enrollment in a randomized Phase II ovarian cancer study. The Gynecologic Oncology Group (GOG) is conducting the randomized Phase II trial of weekly paclitaxel versus weekly paclitaxel with REOLYSIN in patients with persistent or recurrent ovarian, fallopian tube or primary peritoneal cancer (GOG186H).

2 Dec 2010

Frequency News and Research

Excreted antibiotics become potential sources of antibiotic resistant genes

New software predicts key information about nasal insulin treatment regimens in type 1 diabetes

Urgent reform of Medicaid-financed community care for ADHD children needed

L. reuteri Protectis reduces frequency of regurgitation by 80% in infants

Frequent sexual intercourse improves marital satisfaction for neurotic newlyweds

Three abstracts on Defibrotide presented at ASH Annual Meeting

Study examines impact of poor care coordination on quality, cost of care in America

School-based ASMA program helps adolescents improve asthma management, quality of life

Positive data from Celator's CPX-351 Phase 2 study in newly-diagnosed AML presented at 52nd ASH

Mobile phones use during pregnancy linked to behavioural problems in kids: Study

Data analysis reveals significant risk factors for sudden unexpected death in epilepsy

New analysis evaluates association between hemolysis, mortality in patients with PNH

Screening for CCDC40 gene mutations may help determine risk for congenital heart defects

NovaBay Pharmaceuticals, Galderma expand their multi-year collaboration agreement

First patient dosed with rFVIIIFc in A-LONG trial

Mothers exposure to farm animals and cats during pregnancy lowers risk of atopic dermatitis in children

Fourteen cases identified on E. coli infection related to raw milk consumption in Connecticut

Alcohol drinking pattern impacts coronary heart disease

One-third of LGBT youth attempt suicide

Oncolytics initiates enrollment in Phase II ovarian cancer study

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News